Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, China.
Key Laboratory of Kidney Disease Prevention and Control Technology, Zhejiang ProvinceChina.
Intern Med. 2021 Aug 15;60(16):2651-2657. doi: 10.2169/internalmedicine.6640-20. Epub 2021 Mar 8.
We herein report the case of a kidney transplant patient with recurrence of obstructive nephropathy that was not diagnosed as adenine phosphoribosyltransferase (APRT) deficiency until gene testing identified a pathogenic homozygous variant three years after renal transplantation. Subsequently, the patient was treated with allopurinol, and the allograft function increased progressively to normal. In addition, 20 cases of APRT deficiency in renal transplant recipients were also reviewed. We hope this case increases awareness of APRT deficiency in repeated obstructive nephropathy post-transplantation, which is a treatable disease for which the misdiagnosis or delayed diagnosis should be avoided.
我们在此报告一例肾移植患者,其复发性梗阻性肾病在肾移植后三年的基因检测发现致病性纯合变异后才被诊断为腺嘌呤磷酸核糖基转移酶(APRT)缺乏症。随后,该患者接受了别嘌醇治疗,移植物功能逐渐恢复正常。此外,还回顾了 20 例肾移植受者的 APRT 缺乏症病例。我们希望这个病例能够提高人们对移植后复发性梗阻性肾病中 APRT 缺乏症的认识,这是一种可治疗的疾病,应避免误诊或延迟诊断。